Latest Entries
Medical

Eli Lilly $LLY CEO Lechleiter Says Europeans Should Pay More for New Medicines; WSJ

Eli Lilly (LLY) Chief Executive John Lechleiter said in an interview that European nations should pay more for new medicines and warned that the current low prices could pose a threat to innovation in the region, reports the Wall Street Journal. I can’t help but wonder… does Lechleiter really mean it or is he sort of preempting … Continue reading »

Retail

Ascena $ASNA Pops 13% on Fiscal Q2 Results

Ascena Retail Group Inc. (ASNA) is popping, up almost 13% since the markets opened this morning, after reporting its fiscal second quarter results. For the second quarter of 2013, earnings per diluted share from continuing operations decreased to $0.23 per share, while earnings from discontinued operations were $0.06 per share. This compares to diluted earnings … Continue reading »

Technology

Groupon $GRPN has Bigger Problems than Management Issues

“Groupon’s woes won’t end by firing Chief Executive Andrew Mason,” writes Reuters Breaking Views. “The troubled Internet daily deal firm’s stock rallied around 5 percent after the board sent its witty boss packing. But with overseas operations a mess, coupons in decline and a controversial chairman calling the shots, the company has bigger problems.” I … Continue reading »

Economics

Markets Hover Close to All Time Highs; Good Time to Sell?

“U.S. stocks on Thursday were little changed, with equities taking a near-neutral stance after mixed economic data failed to move the needle for benchmark indexes that are within reach of closing highs,” writes MarketWatch. “In position for a monthly gain of 1.6%, the Dow Jones Industrial Average rose 11.48 points, or 0.1%, at 14,086.85, which was … Continue reading »